Release Date: 28/04/21 09:55 Summary: SMX completes strongly subscribed placement Price Sensitive: Yes Download Document 654.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%